Moderna: US Government Received $400 Million in mRNA Royalty Payments

 

• BYPASS THE CENSORS

  Sign up to get unfiltered news delivered straight to your inbox. Email* PhoneThis field is for validation purposes and should be left unchanged.Δ Theepochtimes.com reports: The agreement lets the company use “certain patent rights concerning stabilizing prefusion coronavirus spike proteins and the resulting stabilized proteins for the use in COVID-19 vaccine products,” Mock said. Under the agreement, Moderna sent a “catch-up payment” of $400 million to the NIAID before the new year, according to Moderna executives. NIAID and its parent agency, the U.S. National Institutes of Health (NIH), did not respond to requests for comment. The Epoch Times has filed a Freedom of Information Act request for the agreement.

• NIH Says Wrongly Left Off Patent

  U.S. government researchers were wrongly left off of a patent filing for a key sequence that’s part of the vaccine, according to government officials. NIH scientists were working with Moderna for four years on vaccines for diseases before the pandemic started. After COVID-19 emerged, the NIH and Moderna collaborated to develop the COVID-19 vaccine, both parties have said. The company acknowledges that NIH feels equally strongly that its scientists should be listed as co-inventors for their contemporaneous work on the protein sequence,” Moderna said at the time.“Moderna decided that issuance of the mRNA sequence patent in the current environment could interfere with further discussions aimed at an amicable resolution with the NIH. The U.S. government authorized the vaccine in December 2020, and later granted a biologics license.

• Research conducted at the U.S. Department of Health and Human Services led to more than 4,400 U.S. patents from 1980 to 2019, according to the Government Accountability Office. Those patents generated up to $2 billion in royalty revenue during the same period of time.“The NIH provides limited information to the public about its licensing activities. For example, the agency does not report which of its patents are licensed or release metrics that would enable the public to evaluate how licensing affects patient access to resulting drugs,” the office concluded. &# 8220;Increasing the transparency of its licensing activities could improve the public’s and policymakers’ understanding of NIH’s management of its intellectual property.”Some of the payments go to individual scientists, including Fauci. Open the Books, a nonprofit watchdog, obtained documentation of approximately $350 million in royalties going to Fauci and other government scientists from fiscal year 2010 to fiscal year 2020.Dr.

https://newspunch.com/moderna-us-government-received-400-million-in-mrna-royalty-payments/